Metachronous lung cancer in a patient who cured small cell lung cancer

Creative Commons License

Başoğlu A., Taslak Şengül A., Akpolat I., ÖZBEK OKUMUŞ N., Yucel I.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.28, sa.1, ss.36-40, 2013 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5505/tjoncol.2013.849
  • Dergi Adı: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.36-40
  • Anahtar Kelimeler: Small cell lung cancer, cure, metachronous
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

It is known that the risk of developing a second primary respiratory or digestive tract tumor is high in treated small-cell lung cancers. The study aims to present a patient with metachronous small cell and non-small cell lung cancer. Thirteen years ago, a 78-year-old male patient received chemotherapy and radiotherapy due to limited-stage small cell cancer in the right lung. In the 6th year of the follow-up, he underwent right upper lobectomy due to Stage 2B lung epidermoid carcinoma. Over the 7 years after lobectomy, he has been followed without any problem. In small cell lung cancer patients with a survival more than 2 years, the risk of developing second primary non-small cell lung cancer is 7-16 times higher compared to ones who smoke but do not have cancer. Patients should be followed closely, thus a possible metachronous tumor could be detected at early stages.